Impact of Pandemic Projected for US Breast Cancer Mortality
Cumulative increase of 0.52 percent expected in breast cancer deaths by 2030 due to disruptions during the first six months of the pandemic.
Cumulative increase of 0.52 percent expected in breast cancer deaths by 2030 due to disruptions during the first six months of the pandemic.
Increased rates of cancer seen among women and men and for cancer at multiple sites, including lip, oral cavity, pharynx, respiratory organs.
Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer.
The researchers sought to compare the efficacy of direct oral anticoagulants with that of low molecular heparin for preventing recurrent venous thromboembolism in patients with cancer.
Male breast cancer patients have a high prevalence of cardiovascular comorbidities.